Scilex Holding (SCLX) Non Operating Income (2022 - 2026)

Scilex Holding (SCLX) recorded quarterly Non Operating Income of -$13.5 million in Q1 2026, down 120.74% quarter-over-quarter from $65.0 million in Q4 2025, and down 841.53% on a YoY basis from $1.8 million in Q1 2025.

Scilex Holding (SCLX) Non Operating Income (2022 - 2026) Analysis & Trends

Scilex Holding's Non Operating Income history runs 5 years deep, the most recent figure standing at -$13.5 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 841.53% year-over-year to -$13.5 million; the TTM figure through Mar 2026 stood at -$43.3 million (down 350.33% YoY), while the FY2025 annual figure was -$28.0 million, down 364.64% from the prior year.
  • Non Operating Income was -$13.5 million for Q1 2026 at Scilex Holding, down from $65.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $65.0 million in Q4 2025 to a low of -$71.3 million in Q3 2025.
  • Historically, Non Operating Income has averaged -$538882.4 across 5 years, with a median of -$3.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Non Operating Income surged 817.88% in 2024, then sank 841.53% in 2026.
  • A 5-year view of Non Operating Income shows it stood at $1.9 million in 2022, then sank by 260.94% to -$3.1 million in 2023, then soared by 817.88% to $21.9 million in 2024, then surged by 196.53% to $65.0 million in 2025, then sank by 120.74% to -$13.5 million in 2026.
  • The last three Non Operating Income figures came in at -$13.5 million (Q1 2026), $65.0 million (Q4 2025), and -$71.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 195.49 Mn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -65.00 Mn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn -294.00 Mn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -2.31 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -138.00 Mn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 235.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -861.00 Mn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -32.00 Mn
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn -13.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.48 Mn
Dec 31, 2025 64.99 Mn
Sep 30, 2025 -71.31 Mn
Jun 30, 2025 -23.52 Mn
Mar 31, 2025 1.82 Mn
Dec 31, 2024 21.92 Mn
Sep 30, 2024 15.53 Mn
Jun 30, 2024 -21.96 Mn
Mar 31, 2024 -4.90 Mn
Dec 31, 2023 -3.05 Mn
Sep 30, 2023 3.28 Mn
Jun 30, 2023 -3.84 Mn
Mar 31, 2023 -5.27 Mn
Dec 31, 2022 1.90 Mn
Sep 30, 2022 32.11 Mn
Jun 30, 2022 -6.40 Mn
Mar 31, 2022 3.03 Mn